OPA1
Dynamin-like GTPase OPA1, mitochondrial
Also known as: FLJ12460, KIAA0567, MGM1, NPG, NTG, OPA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60313
- Gene
- OPA1
- Ensembl
- ENSG00000198836
- Chromosome
- 3
- Canonical length
- 960 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
The protein encoded by this gene is a nuclear-encoded mitochondrial protein with similarity to dynamin-related GTPases. The encoded protein localizes to the inner mitochondrial membrane and helps regulate mitochondrial stability and energy output. This protein also sequesters cytochrome c. Mutations in this gene have been associated with optic atrophy type 1, which is a dominantly inherited optic neuropathy resulting in progressive loss of visual acuity, leading in many cases to legal blindness. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
960 residues, UniProt reviewed canonical sequence.
>O60313|OPA1
1 MWRLRRAAVA CEVCQSLVKH SSGIKGSLPL QKLHLVSRSI YHSHHPTLKL QRPQLRTSFQ
61 QFSSLTNLPL RKLKFSPIKY GYQPRRNFWP ARLATRLLKL RYLILGSAVG GGYTAKKTFD
121 QWKDMIPDLS EYKWIVPDIV WEIDEYIDFE KIRKALPSSE DLVKLAPDFD KIVESLSLLK
181 DFFTSGSPEE TAFRATDRGS ESDKHFRKVS DKEKIDQLQE ELLHTQLKYQ RILERLEKEN
241 KELRKLVLQK DDKGIHHRKL KKSLIDMYSE VLDVLSDYDA SYNTQDHLPR VVVVGDQSAG
301 KTSVLEMIAQ ARIFPRGSGE MMTRSPVKVT LSEGPHHVAL FKDSSREFDL TKEEDLAALR
361 HEIELRMRKN VKEGCTVSPE TISLNVKGPG LQRMVLVDLP GVINTVTSGM APDTKETIFS
421 ISKAYMQNPN AIILCIQDGS VDAERSIVTD LVSQMDPHGR RTIFVLTKVD LAEKNVASPS
481 RIQQIIEGKL FPMKALGYFA VVTGKGNSSE SIEAIREYEE EFFQNSKLLK TSMLKAHQVT
541 TRNLSLAVSD CFWKMVRESV EQQADSFKAT RFNLETEWKN NYPRLRELDR NELFEKAKNE
601 ILDEVISLSQ VTPKHWEEIL QQSLWERVST HVIENIYLPA AQTMNSGTFN TTVDIKLKQW
661 TDKQLPNKAV EVAWETLQEE FSRFMTEPKG KEHDDIFDKL KEAVKEESIK RHKWNDFAED
721 SLRVIQHNAL EDRSISDKQQ WDAAIYFMEE ALQARLKDTE NAIENMVGPD WKKRWLYWKN
781 RTQEQCVHNE TKNELEKMLK CNEEHPAYLA SDEITTVRKN LESRGVEVDP SLIKDTWHQV
841 YRRHFLKTAL NHCNLCRRGF YYYQRHFVDS ELECNDVVLF WRIQRMLAIT ANTLRQQLTN
901 TEVRRLEKNV KEVLEDFAED GEKKIKLLTG KRVQLAEDLK KVREIQEKLD AFIEALHQEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OPA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- tongue: 42 nTPM
- heart muscle: 37 nTPM
- skeletal muscle: 30 nTPM
- bone marrow: 24 nTPM
- cerebral cortex: 22 nTPM
- parathyroid gland: 22 nTPM
Single-cell type
- neutrophil progenitors: 193 nCPM
- adrenal cortex cells: 164 nCPM
- choroid plexus epithelial cells: 157 nCPM
- lactotrophs: 155 nCPM
- myonuclei: 147 nCPM
- pituicytes/fscs: 145 nCPM
Immune cell
- non-classical monocyte: 18 nTPM
- basophil: 9.6 nTPM
- intermediate monocyte: 8.2 nTPM
- myeloid DC: 7.8 nTPM
- classical monocyte: 7.3 nTPM
- eosinophil: 7.1 nTPM
Brain region
- cerebral cortex: 49 nTPM
- hypothalamus: 46 nTPM
- basal ganglia: 45 nTPM
- pons: 45 nTPM
- medulla oblongata: 43 nTPM
- midbrain: 42 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OPA1.
Disease | AllUniProt
Conditions OPA1 is implicated in, by any mechanism.
- Optic atrophy 1 (OPA1) MIM:165500
- Optic atrophy plus syndrome (DOA+) MIM:125250
- Behr syndrome (BEHRS) MIM:210000
- Mitochondrial DNA depletion syndrome 14, cardioencephalomyopathic type (MTDPS14) MIM:616896
Disease | GeneticClinVar
374 pathogenic / likely-pathogenic of 1,797 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Optic atrophy
- Autosomal dominant optic atrophy classic form
- Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
- OPA1-related disorder
- Abortive cerebellar ataxia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.97
- DepMap mean gene effect
- -0.46
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 15% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- axonal transport of mitochondrion
- cellular senescence
- cristae formation
- GTP metabolic process
- inner mitochondrial membrane organization
- membrane tubulation
- mitochondrial fission
- mitochondrial fusion
- mitochondrion organization
- negative regulation of apoptotic process
- negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
- negative regulation of release of cytochrome c from mitochondria
- neural tube closure
- peroxisome fission
- positive regulation of interleukin-17 production
- positive regulation of T-helper 17 cell lineage commitment
- protein complex oligomerization
- visual perception
- mitochondrial inner membrane fusion
Molecular functions
- cardiolipin binding
- GTP binding
- GTPase activity
- GTPase-dependent fusogenic activity
- magnesium ion binding
- microtubule binding
- phosphatidic acid binding
- membrane bending activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dynamin, GTPase domain
- Dynamin
- P-loop containing nucleoside triphosphate hydrolase
- Dynamin-type guanine nucleotide-binding (G) domain
- Dynamin, N-terminal
- Dynamin family
- Dynamin-like GTPase OPA1, C-terminal
- Dynamin-like GTPase OPA1 C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OPA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OPA1 as an antibody target. Whether an autoantibody or antibody against OPA1 could matter depends on whether native OPA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OPA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OPA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...